Friday, November 29, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
2022 Watch List

Revive Therapeutics (RVVTF) Annual Shareholder Meeting.

Editor / Curator -
AI Artificial Intelligence

Corporate Presentation: Internet of Things Innovator, Direct Communication (DCSX).

Editor / Curator -
All News

Nu-Med Plus (NUMD) on the Tape.

Editor / Curator -
Featured

Adding Iconic Brands (ICNB) $0.20 to Watch List.

Editor / Curator -
All News

Top Private Label Beverages Manufacturers and Companies in the USA (ThomasNet)

Editor / Curator -
All News

13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)

Editor / Curator -
AI Artificial Intelligence

DCS (DCSX) Announces Closing of Fully Subscribed USD $1.5 Million Private...

Editor / Curator -
2022 Watch List

Adding Progressive Care (RXMD) $0.04 to Watch List.

Editor / Curator -
All News

CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.

Editor / Curator -
2022 Watch List

Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules...

Editor / Curator -
1...272829...93Page 28 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.